Company

CDT Equity Inc.

Public

CDT Equity Inc. is a data-driven biopharmaceutical company focused on identifying, enhancing, and advancing high-potential therapeutic assets through artificial intelligence, solid-form chemistry, and strategic partnerships.

CDT Equity Inc. is a publicly traded company. Leadership tracked by CEOInsider includes James Bligh (CEO).

www.cdtequity.com ↗

Leadership

Current

James Bligh

CEO

Recent developments

AI summary of recent coverage

Recent coverage of CDT Equity has focused on significant leadership changes, including the appointment of co-founder James Bligh as Chief Executive Officer effective August 31, with former CEO Andrew Regan stepping down. The news of Bligh's appointment coincided with a sharp 21% decline in CDT Equity's share price after hours trading. Additionally, coverage has noted that CDT Equity obtained shareholder approval for a reverse stock split and made strategic investments, including funding provided to Pepd Inc.

Summarized from the headlines in the sidebar; see each source for the full story.